Short communication expression and localization of cytosolic sulfotransferase (SULT) 1A1 and SULT1A3 in normal human brain

Drug Metabolism and Disposition

Volumn 37, Issue 4, 2009, Pages 706-709

  Salman, Emily D ^a   Kadlubar, Susan A ^b   Falany, Charles N ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; NEUROTRANSMITTER; PHENOL; SULFOTRANSFERASE; SULFOTRANSFERASE 1A1; SULFOTRANSFERASE 1A3; UNCLASSIFIED DRUG; ARYL SULFOTRANSFERASE; MONOAMINE SULFATING PHENOL SULFOTRANSFERASE; MONOAMINE-SULFATING PHENOL SULFOTRANSFERASE; SULT1A1 PROTEIN, HUMAN;

ADULT; ARTICLE; BRAIN; CELLULAR DISTRIBUTION; CEREBELLUM; CINGULATE GYRUS; CYTOSOLIC FRACTION; FEMALE; FRONTAL LOBE; GLIA CELL; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; METABOLISM; NERVE CELL; OCCIPITAL LOBE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TEMPORAL LOBE; CYTOSOL; ENZYMOLOGY; WESTERN BLOTTING;

ARYLSULFOTRANSFERASE; BLOTTING, WESTERN; BRAIN; CYTOSOL; HUMANS; IMMUNOHISTOCHEMISTRY; SULFOTRANSFERASES;

EID: 63849173713     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.108.025767     Document Type: Article

References (32)

1. Alnouti Y and Klaassen CD (2006) Tissue distribution and ontogeny of sulfotransferase enzymes in mice. Toxicol Sci 93:242-255.
2. Bardakci F, Arslan S, Bardakci S, Binatli AO, and Budak M (2008) Sulfotransferase 1A1 (SULT1A1) polymorphism and susceptibility to primary brain tumors. J Cancer Res Clin Oncol 134:109-114.
3. Blanchard RL, Freimuth RR, Buck J, Weinshilboum RM, and Coughtrie MW (2004) A proposed nomenclature system for the cytosolic sulfotransferase (SULT) superfamily. Pharmacogenetics 14:199-211.
4. Dooley TP, Obermoeller RD, Leiter EH, Chapman HD, Falany CN, Deng Z, and Siciliano MJ (1993) Mapping of the phenol sulfotransferase gene (STP) to human chromosome 16p12.1-p11.2. Genomics 18:440 -443.
5. Falany CN (1991) Molecular enzymology of human liver cytosolic sulfotransferases. Trends Pharmacol Sci 12:255-259.
6. Falany JL, Lawing L, and Falany CN (1993) Identification and characterization of cytosolic sulfotransferase activities in MCF-7 human breast carcinoma cells. J Steroid Biochem Mol Biol 46:481-487.
7. Falany CN, He D, Dumas N, Frost AR, and Falany JL (2006) Human cytosolic sulfotransferase 2B1: isoform expression, tissue specificity and subcellular localization. J Steroid Biochem Mol Biol 102:214-221.
8. Falany C (2004). Human cytosolic sulfotransferases: properties, physiological functions, and toxicology, in Methods in Pharmacology and Toxicology, Drug Metabolism and Transport: Molecular Methods and Mechanism (Lash LH ed) pp 341-378, Humana Press, Totowa.
9. Falany CN, Xie X, Wang J, Ferrer J, and Falany JL (2000) Molecular cloning and expression of novel sulfotransferase-like cDNAs from human and rat brain. Biochem J 346:857-864.
10. Gjerde J, Hauglid M, Breilid H, Lundgren S, Varhaug JE, Kisanga ER, Mellgren G, Steen VM, and Lien EA (2008) Effects of CYP2D6 and SULT1A1 genotypes including SULT1A1 copy number on tamoxifen metabolism. Ann Oncol 19:56-61.
11. Glatt HR (2000) An overview of bioactivation and chemical carcinogens. Biochem Soc Trans 28:1-6.
12. Hart RF, Renskers KJ, Nelson EB, and Roth JA (1979) Localization and characterization of phenol sulfotransferase in human platelets. Life Sci 24:125-130.
13. Hempel N, Gamage N, Martin JL, and McManus ME (2007) Human cytosolic sulfotransferase SULT1A1. Int J Biochem Cell Biol 39:685-689.
14. Hempel N, Negishi M, and McManus ME (2005) Human SULT1A genes: cloning and activity assays of the SULT1A promoters. Meth Enzymol 400:147-165.
15. Kern J, Grannemann BD, Trivedi MH, Waring RH, Ramsden DB, and Garver CR (2004) Abnormal sulfation chemistry in autism, in Trends in Autism Research (Ryaskin OT ed) pp 197-219, Nova Science Publishers, Hauppauge.
16. Kumar RM, KaraMohamed S, Sudi J, Conrad DF, Brune C, Badner JA, Gilliam TC, Nowak NJ, Cook EH Jr, Dobyns WB, et al. (2008) Recurrent 16p11.2 microdeletions in autism. Hum Mol Genet 17:628-638.
17. Meloche C (2003). Activity and Expression of the SULT2B1 Isoforms in Human Prostate, Placenta, Breast and Skin. Doctoral dissertation, University of Alabama at Birmingham, Birmingham, AL.
18. Nowell S and Falany CN (2006) Pharmacogenetics and human cytosolic sulfotransferases. Oncogene 25:1673-1678.
19. Raftogianis RB, Wood TC, Otterness DM, Van Loon JA, and Weinshilboum RM (1997) Phenol sulfotransferase pharmacogenetics in humans: association of common SULT1A1 alleles with TS PST phenotype. Biochem Biophys Res Commun 239:298-304.
20. Richard K, Hume R, Kaptein E, Stanley EL, Visser TJ, and Coughtrie MW (2001) Sulfation of thyroid hormone and dopamine during human development: ontogeny of phenol sulfotransferases and arylsulfatase in liver, lung, and brain. J Clin Endocrinol Metab 86:2734-2742.
21. Stanley EL, Hume R, and Coughtrie MW (2005) Expression profiling of human fetal cytosolic sulfotransferases involved in steroid and thyroid hormone metabolism and detoxification. Mol Cell Endocrinol 240:32-42.
22. Teubner W, Meinl W, Florian S, Kretzschmar M, and Glatt H (2007) Identification and localization of soluble sulfotransferases in the human gastrointestinal tract. Biochem J 404:207-215.
23. Vietri M, Vaglini F, Cantini R, and Pacifici GM (2003) Quercetin inhibits the sulfation of r(-)-apomorphine in human brain. Int J Clin Pharmacol Ther 41:30-35.
24. Waring R and Klovrza LV (2000) Sulphur metabolism in autism. J Nutri Environ Med 10:25-32.
25. Waring R, Ngong JM, Klovrza L, Green S, and Sharp H (1997) Biochemical parameters in autistic children. Devel Brain Dysfunct 10:40-43.
26. Weinshilboum RM, Otterness DM, Aksoy IA, Wood TC, Her C, and Raftogianis RB (1997) Sulfation and sulfotransferases 1: sulfotransferase molecular biology: cDNAs and genes. FASEB J 11:3-14.
27. Weiss LA, Shen Y, Korn JM, Arking DE, Miller DT, Fossdal R, Saemundsen E, Stefansson H, Ferreira MAR, Green T, et al. (2008) Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med 358:667-675.
28. Whiteley P and Shattock P (2002) Biochemical aspects in autism spectrum disorders: updating the opioid-excess theory and presenting new opportunities for intervention. Expert Opin Ther Targets 6:175-183.
29. Whittemore RM, Pearce LB, and Roth JA (1986) Purification and kinetic characterization of pheno-sulfating form of phenol sulfotransferase from human brain. Arch Biochem Biophys 249:464-471.
30. Yasuda S, Liu MY, Suiko M, Sakakibara Y, and Liu MC (2007). Hydroxylated serotonin and dopamine as substrates and inhibitors for human cytosolic SULT1A3. J Neurochem 103:2679-2689.
31. Young WF Jr, Gorman CA, and Weinshilboum RM (1988) Triiodothyronine: a substrate for the thermostable and thermolabile forms of human phenol sulfotransferase. Endocrinology 122:1816-1824.
32. Zou JY, Petney R, and Roth JA (1990) Immunohistochemical detection of phenol sulfotransferase-containing neurons in human brain. J Neurochem 55:1154-1158.